These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7036848)

  • 1. Pharmacokinetics of trimethoprim and tetroxoprim. A review.
    Hengstmann JH
    Antibiot Chemother (1971); 1982; 31():211-25. PubMed ID: 7036848
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal handling and lymph concentration of tetroxoprim and metioprim: an experimental study in dogs.
    Iversen P; Vergin H; Madsen PO
    J Urol; 1984 Aug; 132(2):362-4. PubMed ID: 6737599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal elimination kinetics of tetroxoprim and sulfadiazine in patients with renal insufficiency].
    Vergin H; Reutter FW; Sieber R; Ferber H
    Arzneimittelforschung; 1980; 30(2):313-7. PubMed ID: 7378111
    [No Abstract]   [Full Text] [Related]  

  • 4. A bioavailability study on three oral preparations of the combination trimethoprim-sulfamethoxazole.
    Langlois Y; Gagnon MA; Tétreault L
    J Clin Pharmacol New Drugs; 1972; 12(5):196-200. PubMed ID: 4555878
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on sulfamethoxazole-trimethoprim. Absorption, distribution, excretion and metabolism of trimethoprim in rat.
    Meshi T; Sato Y
    Chem Pharm Bull (Tokyo); 1972 Oct; 20(10):2079-90. PubMed ID: 4650364
    [No Abstract]   [Full Text] [Related]  

  • 6. Pancreatic secretion of benzylpyrimidines. Experimental studies in dogs.
    Vergin H; Bishop-Freudling GB; Merk K; Szelenyi I
    Arzneimittelforschung; 1982; 32(10):1302-4. PubMed ID: 6891232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of long half-life antibacterials.
    Follath F
    J Antimicrob Chemother; 1979 Nov; 5(B):97-102. PubMed ID: 536350
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of trimethoprim 3-oxide as a new urinary metabolite of trimethoprim in man.
    Sigel CW; Brent DA
    J Pharm Sci; 1973 Apr; 62(4):694-5. PubMed ID: 4699000
    [No Abstract]   [Full Text] [Related]  

  • 9. Distribution and elimination of trimethoprim in pregnant and newborn rats.
    Schulz R
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 272(4):369-77. PubMed ID: 4260257
    [No Abstract]   [Full Text] [Related]  

  • 10. [Kinetic studies on a chemotherapeutic drug combination (sulfamethoxazole and trimethoprim) in chronic kidney insufficiency].
    Gahl G; Baethke R; Gassner O; Kessel M
    Verh Dtsch Ges Inn Med; 1971; 77():1017-9. PubMed ID: 5155954
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tissue distribution of 14C-tetroxoprim in the rat (author's transl)].
    Vergin H
    Arzneimittelforschung; 1980; 30(2):309-13. PubMed ID: 7378110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bioavailability of the trimethoprim-sulfamethoxazole association in suspensions with different granulometry].
    Bernareggi V; Bugada G; Cassola A; Levi G; Moncalvo F
    Boll Chim Farm; 1973 Mar; 112(3):177-90. PubMed ID: 4721642
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioavailability study of Sumetrolim syrup.
    Arr M
    Ther Hung; 1983; 31(2):75-9. PubMed ID: 6336276
    [No Abstract]   [Full Text] [Related]  

  • 14. Trimethoprim, metioprim, tetroxoprim, and RO 10-5970 in canine bone.
    Iversen P; Madsen PO
    Acta Pharmacol Toxicol (Copenh); 1982 Nov; 51(5):446-9. PubMed ID: 7164825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Trimethoprim levels in the serum, cerebrospinal fluid, and tissues of the guinea pig].
    Tiesler E; Schmitt D
    Arzneimittelforschung; 1973 Mar; 23(3):463-6. PubMed ID: 4196577
    [No Abstract]   [Full Text] [Related]  

  • 16. [Residues in tissues of laboratory and domestic animals following application of the drug combination sulfadoxin-trimethoprim].
    Rehm WF; Thommen H; Vuilleumier JP; Weiser H
    Berl Munch Tierarztl Wochenschr; 1972 Jun; 85(12):228-34. PubMed ID: 5047128
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of tetroxoprim/sulphadiazine in patients with impaired renal function.
    Reutter FW; Vergin H; Sieber R; Ferber H
    J Antimicrob Chemother; 1979 Nov; 5(B):149-58. PubMed ID: 536339
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics of metioprim in normal subjects and patients with impaired renal function.
    Vergin H; Bishop-Freudling GB; Kaiser W; Köhler M; Strobel K; Reutter FW
    Antimicrob Agents Chemother; 1983 Aug; 24(2):190-3. PubMed ID: 6638987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the pharmacokinetics and tissue residues of an oral trimethoprim/sulphadiazine formulation in healthy pigs.
    Garwacki S; Lewicki J; Wiechetek M; Grys S; Rutkowski J; Zaremba M
    J Vet Pharmacol Ther; 1996 Dec; 19(6):423-30. PubMed ID: 8971670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetroxoprim-sulphadiazine distribution in canine prostate.
    Nielsen OS; Iversen P; Vergin H; Madsen PO
    J Antimicrob Chemother; 1982 Mar; 9(3):240-2. PubMed ID: 7076606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.